Sionna Therapeutics (SION) Current Leases (2024 - 2026)

Sionna Therapeutics has disclosed Current Leases across 3 years of filings, most recently posting $1.3 million for Q1 2026.

• Current Leases for Q1 2026 came in at $1.3 million, up 18.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 18.14% YoY), and the FY2025 annual result was $1.3 million, up 18.38% from the prior year.
• Current Leases came in at $1.3 million for Q1 2026 at Sionna Therapeutics, up from $1.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.3 million in Q1 2026 to a low of $1.1 million in Q4 2024.
• The 3-year median for Current Leases is $1.2 million (2025), against an average of $1.2 million.
• Across the five-year window, Current Leases advanced 18.38% in 2025 and grew 18.14% in 2026, its largest moves.
• Sionna Therapeutics' Current Leases stood at $1.1 million in 2024, then gained by 18.38% to $1.3 million in 2025, then gained by 4.18% to $1.3 million in 2026.
• The last three Current Leases figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.